Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 5/20 | 0.72 |
| ▸ | DHFR | P00374 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14682231 | 1.00 | TK1 (0.72) | TK1DHFRPOLB | |
| SCHEMBL2056693 | 1.00 | TK1 (0.72) | TK1DHFRPOLB | |
| Iodide SCHEMBL8583592 | 0.99 | TK1 (0.70) | TK1DHFRPOLB | |
| Hydrochloric Acid SCHEMBL8585203 | 0.99 | TK1 (0.70) | TK1DHFRPOLB | |
| SCHEMBL12718422 | 0.93 | TK1 (0.67) | TK1DHFRPOLB | |
| SCHEMBL17236359 | 0.93 | TK1 (0.67) | TK1DHFRPOLB | |
| SCHEMBL12718420 | 0.92 | TK1 (0.66) | TK1DHFR | |
| SCHEMBL14590480 | 0.87 | TK1 (0.59) | TK1DHFR | |
| SCHEMBL7200634 | 0.86 | TK1 (0.69) | TK1DHFRPOLB | |
| SCHEMBL4348630 | 0.86 | TK1 (0.69) | TK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1131270-B1 | PROCESS FOR CONVERTING AN ALCOHOL TO THE CORRESPONDING FLUORIDE | 3M INNOVATIVE PROPERTIES CO (US) | 2004-04-07 | — | — | EP | claimed |
| US-6248889-B1 | FORMING MIXTURE COMPRISING AT LEAST ONE FLUORINATED, SATURATED ALIPHATIC OR ALICYCLIC SULFONYL FLUORIDE AND AT LEAST ONE PRIMARY OR SECONDARY ALCOHOL, ADDING MOLAR EXCESS OF STRONG, APROTIC, NON-NUCLEOPHILIC HINERED ORGANIC BASE | 3M INNOVATIVE PROPERTIES COMPANY | 2001-06-19 | — | — | US | claimed |
| EP-0360820-B1 | OLIGOBIPYRIDINE LIGANDS, PROCESS FOR OBTAINING THEM AND APPLICATION AS COMPLEXING AGENTS | CIS BIO INTERNATIONAL (FR) | 1992-08-19 | — | — | EP | claimed |
| EP-0360820-A1 | OLIGOBIPYRIDINE LIGANDS, PROCESS FOR OBTAINING THEM AND APPLICATION AS COMPLEXING AGENTS. | ORIS SA (FR) | 1990-04-04 | — | — | EP | claimed |
| WO-1988008419-A1 | OLIGOBIPYRIDINE LIGANDS, PROCESS FOR OBTAINING THEM AND APPLICATION AS COMPLEXING AGENTS | COMPAGNIE ORIS INDUSTRIE S.A. (FR) | 1988-11-03 | — | — | WO | claimed |
| EP-4745237-A1 | RNAI AGENT FOR INHIBITING EXPRESSION OF KETOHEXOKINASE AND USE THEREOF | YUN HO BIO CO., LTD (CN) | 2026-05-20 | — | — | EP | disclosed |
| EP-4722363-A1 | RNAI AGENT FOR INHIBITING ANGPTL3 EXPRESSION AND USE THEREOF | YUN HO BIO CO., LTD (CN) | 2026-04-08 | — | — | EP | disclosed |
| EP-4634385-A2 | RNAI CONSTRUCTS FOR INHIBITING TTR EXPRESSION AND METHODS OF USE THEREOF | AMGEN INC. (US) | 2025-10-22 | — | — | EP | disclosed |
| US-20250320502-A1 | RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF | AMGEN INC. (US) | 2025-10-16 | — | — | US | disclosed |
| US-20250313834-A1 | RNAI CONSTRUCTS FOR INHIBITING SCAP EXPRESSION AND METHODS OF USE THEREOF | AMGEN INC. (US) | 2025-10-09 | — | — | US | disclosed |
| US-20250207138-A1 | RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF | AMGEN INC. (US) | 2025-06-26 | — | — | US | disclosed |
| EP-4562152-A2 | RNAI CONSTRUCTS AND METHODS FOR INHIBITING FAM13A EXPRESSION | Amgen Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| US-5910406-A | HYBRIDIZING ON SOLID SUPPORT | TEPNEL MEDICAL LIMITED (GB) | 1999-06-08 | — | — | US | disclosed |
| US-5777092-A | Heteroatomic oligonucleoside linkages | ISIS PHARMACEUTICALS, INC. (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0767668-A4 | POLYNUCLEOSIDE CHAIN HAVING MULTIPLE NUCLEOSIDES, THE NUCLEOSIDES COUPLED BY GUANIDYL LINKAGES | UNIV CALIFORNIA (US) | 1998-04-08 | — | — | EP | disclosed |
| EP-0767668-A1 | POLYNUCLEOSIDE CHAIN HAVING MULTIPLE NUCLEOSIDES, THE NUCLEOSIDES COUPLED BY GUANIDYL LINKAGES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-04-16 | — | — | EP | disclosed |
| EP-0348458-B1 | DNA MOLECULES STABILIZED BY MODIFICATIONS OF THE 3'-TERMINAL PHOSPHODIESTER LINKAGE AND THEIR USE AS NUCLEIC ACID PROBES AND AS THERAPEUTIC AGENTS TO BLOCK THE EXPRESSION OF SPECIFICALLY TARGETED GENES | UNIV IOWA RES FOUND (US) | 1997-04-09 | — | — | EP | disclosed |
| US-5491133-A | CONTACTING EUKARYOTIC CELL IN VITRO WITH OLIGODEOXYNUCLEOTIDE WHICH HAS COMPLEMENTARITY FOR AND IS HYBRIDIZABLE TO SPECIFED MESSENGER RNA REGION AND HAS MODIFIED PHOSPHODIESTER LINKAGE RESISTANT TO EXONUCLEASE DEGRADATION | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1996-02-13 | — | — | US | disclosed |
| WO-1996000575-A1 | POLYNUCLEOSIDE CHAIN HAVING MULTIPLE NUCLEOSIDES, THE NUCLEOSIDES COUPLED BY GUANIDYL LINKAGES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-01-11 | — | — | WO | disclosed |
| WO-1989005358-A1 | DNA AND RNA MOLECULES STABILIZED BY MODIFICATIONS OF THE 3'-TERMINAL PHOSPHODIESTER LINKAGE AND THEIR USE AS NUCLEIC ACID PROBES AND AS THERAPEUTIC AGENTS TO BLOCK THE EXPRESSION OF SPECIFICALLY TARGETED GENES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1989-06-15 | — | — | WO | disclosed |